The Extent, Quality and Features of HIV Costs Evaluation Publications in Nigeria
A Systematic Review
-
Giwa Halima Bukola
,
Davari Majid
,
Nabizade Azita
,
Giwa abdulganiyu
,
Muslim Olakunle Jamiu
,
N S Njinga
,
Abdulraheem Abdul
,
Ibrahim Oluwasegun Eniayewu
,
Fatihu Abulfatihi Salaudeen -Giwa
Abstract
Objective: Nigeria bears a high prevalence of HIV, and donor funding for HIV programs has been known to decline in previous years. This makes the judicious use of healthcare resources paramount. Cost evaluation is important for sustainable HIV financing and policy decisions, however, the scope and quality of HIV cost evaluation studies are unknown. This systematic review investigates the scope, methodological quality, and features of published HIV cost evaluation studies, with the intent of highlighting knowledge gaps and strengthening economic evidence base for HIV program planning. Method and Results: A search for some databases was conducted using relevant search strategies. Eleven HIV Cost evaluation studies published in 9 journals outside Nigeria were identified. Based on a 14 point score, the mean score of the studies was found to be 10.56. Five studies were rated fair andsix rated good. The quality of the study was not significantly related to the country, type of publication and funding source (p>0.05). There was no significant correlation between the quality of studies and number of authors, year of publication, cost estimates and sample size (p>0.05.The studies captured HIV related cost outcomes which included direct medical costs, willingness to pay, catastrophic expenditures, and the cost effects of decentralization. Non of the studies assessed indirect medical cost. Conclusion: HIV Cost evaluation studies were found to be limited in number though of good quality, All published in foreign journals.This emphasizes the need for building indigenous research expertise, promoting dissemination in local or African journals and encouraging research policy partnerships.Rascati, K. L., Drummond Mf Fau - Annemans, L., Annemans L Fau - Davey, P. G., & Davey, P. G. Education in pharmacoeconomics: an international multidisciplinary view. (1170-7690 (Print)).
Mittmann, N., & de Oliveira, C. (2016). Importance of cost estimates and cost studies. Current oncology (Toronto, Ont.), 23(Suppl 1), S6-S6. doi:10.3747/co.23.3154
van Sighem, A. I., Gras, L. A., Reiss, P., Brinkman, K., & de Wolf, F. (2010). Life expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individuals. Aids, 24(10), 1527-1535. doi:10.1097/QAD.0b013e32833a3946
Williams, B. G., Lima, V., & Gouws, E. (2011). Modelling the impact of antiretroviral therapy on the epidemic of HIV. Curr HIV Res, 9(6), 367-382. doi:10.2174/157016211798038533
Trapero-Bertran, M., & Oliva-Moreno, J. (2014). Economic impact of HIV/AIDS: a systematic review in five European countries. Health economics review, 4(1), 15. doi:10.1186/s13561-014-0015-5
Kushitor, M. K., & Boatemaa, S. (2018). The double burden of disease and the challenge of health access: Evidence from Access, Bottlenecks, Cost and Equity facility survey in Ghana. PLoS One, 13(3), e0194677.doi:10.1371/journal.pone.0194677
Gavaza, P., Rascati, K. L., Oladapo, A. O., & Khoza, S. (2010). The state of health economic evaluation research in Nigeria: a systematic review. Pharmacoeconomics, 28(7), 539-553. doi:10.2165/11536170-000000000-00000
Aliyu, H. B., Chuku, N. N., Kola-Jebutu, A., Abubakar, Z., Torpey, K., & Chabikuli, O. N. (2012). What is the cost of providing outpatient HIV counseling and testing and antiretroviral therapy services in selected public health facilities in Nigeria? J Acquir Immune Defic Syndr, 61(2), 221-225. doi:10.1097/QAI.0b013e3182683b04
Haakenstad, A., Moses, M. W., Tao, T., Tsakalos, G., Zlavog, B., Kates, J., . . . Dieleman, J. L. (2019). Potential for additional government spending on HIV/AIDS in 137 low-income and middle-income countries: an economic modelling study. Lancet HIV, 6(6), e382-e395. doi:10.1016/s2352-3018(19)30038-4
Ouattara, E. N., MacLean, R. L., Danel, C., Borre, E. D., Gabillard, D., Huang, M., . . . Freedberg, K. A. (2019). Cost-effectiveness and budget impact of immediate antiretroviral therapy initiation for treatment of HIV infection in Côte d'Ivoire: A model-based analysis. PloS one, 14(6), e0219068-e0219068. doi:10.1371/journal.pone.0219068
Gavaza, P., Rascati, K., Brown, C., Lawson, K., & Mann, T. (2008). The state of health economic and pharmacoeconomic evaluation research in Zimbabwe: A review. Curr Ther Res Clin Exp, 69(3), 268-285. doi:10.1016/j.curtheres.2008.06.005
Jiang, S., Ma, X., Desai, P., Yang, L., & Rascati, K. (2014). A Systematic Review on the Extent and Quality of Pharmacoeconomic Publications for China. Value Health Reg Issues, 3, 79-86. doi:10.1016/j.vhri.2014.02.010
Moher D Fau - Liberati, A., Liberati A Fau - Tetzlaff, J., Tetzlaff J Fau - Altman, D. G., & Altman, D. G. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. (1743-9159 (Electronic)).
Drummond, M. F., Sculpher, M. J., Torrance, G. W., O'Brien, B. J., & Stoddart, G. L. (2005). Methods for the economic evaluation of health care programme. Third edition: Oxford: Oxford University Press.
Gavaza, P., Rascati, K. L., Oladapo, A. O., & Khoza, S. (2012). The state of health economic research in South Africa: a systematic review. Pharmacoeconomics, 30(10), 925-940. doi:10.2165/11589450-000000000-00000
Watts, R. D., & Li, I. W. (2019). Use of Checklists in Reviews of Health Economic Evaluations, 2010 to 2018. Value in Health, 22(3), 377-382. doi:https://doi.org/10.1016/j.jval.2018.10.006
Bautista-Arredondo, S., Colchero, M. A., Amanze, O. O., La Hera-Fuentes, G., Silverman-Retana, O., Contreras-Loya, D., . . . Ogungbemi, K. M. (2018). Explaining the heterogeneity in average costs per HIV/AIDS patient in Nigeria: The role of supply-side and service delivery characteristics. PLoS One, 13(5), e0194305. doi:10.1371/journal.pone.0194305
Menzies, N. A., Berruti, A. A., Berzon, R., Filler, S., Ferris, R., Ellerbrock, T. V., & Blandford, J. M. (2011). The cost of providing comprehensive HIV treatment in PEPFAR-supported programs. Aids, 25(14), 1753-1760. doi:10.1097/QAD.0b013e3283463eec
Menzies, N. A., Berruti, A. A., & Blandford, J. M. (2012). The determinants of HIV treatment costs in resource limited settings. PLoS One, 7(11), e48726. doi:10.1371/journal.pone.0048726
Etiaba, E., Onwujekwe, O., Torpey, K., Uzochukwu, B., & Chiegil, R. (2016). What Is the Economic Burden of Subsidized HIV/AIDS Treatment Services on Patients in Nigeria and Is This Burden Catastrophic to Households? PLoS One, 11(12), e0167117. doi:10.1371/journal.pone.0167117
Onwujekwe, O. E., Ibe, O., Torpey, K., Dada, S., Uzochukwu, B., & Sanwo, O. (2016). Examining geographic and socio-economic differences in outpatient and inpatient consumer expenditures for treating HIV/AIDS in Nigeria. J Int AIDS Soc, 19(1), 20588. doi:10.7448/ias.19.1.20588
Mbachu, C., Okoli, C., Onwujekwe, O., & Enabulele, F. (2018). Willingness to pay for antiretroviral drugs among HIV and AIDS clients in south-east Nigeria. Health Expect, 21(1), 270-278. doi:10.1111/hex.12612
Uzochukwu, B., Uguru, N., Ezeoke, U., Onwujekwe, O., & Sibeudu, T. (2011). Voluntary counseling and testing (VCT) for HIV/AIDS: a study of the knowledge, awareness and willingness to pay for VCT among students in tertiary institutions in Enugu State Nigeria. Health Policy, 99(3), 277-284. doi:10.1016/j.healthpol.2010.11.007
Johns, B., & Baruwa, E. (2016). The effects of decentralizing anti-retroviral services in Nigeria on costs and service utilization: two case studies. Health Policy Plan, 31(2), 182-191. doi:10.1093/heapol/czv040
Grosso, A., Ryan, O., Tram, K. H., & Baral, S. (2015). Financing the response to HIV among gay men and other men who have sex with men: Case studies from eight diverse countries. Glob Public Health, 10(10), 1172-1184. doi:10.1080/17441692.2015.1043314
Krivelyova, A., Kakietek, J., Connolly, H., Bonnel, R., Manteuffel, B., Rodriguez-Garcia, R., . . . Agrawal, R. (2013). Funding and expenditure of a sample of community-based organizations in Kenya, Nigeria, and Zimbabwe. AIDS Care, 25 Suppl 1, S20-29. doi:10.1080/09540121.2013.764390
Lee, K. S., Brouwer, W. B., Lee, S. I., & Koo, H. W. (2005). Introducing economic evaluation as a policy tool in Korea: will decision makers get quality information? : a critical review of published Korean economic evaluations. Pharmacoeconomics, 23(7), 709-721. doi:10.2165/00019053-200523070-00005
Walker, D., & Fox-Rushby, J. A. (2000). Economic evaluation of communicable disease interventions in developing countries: a critical review of the published literature. Health Econ, 9(8), 681-698. doi:10.1002/1099-1050(200012)9:8<681::aid-hec545>3.0.co;2-x
Hargreaves, S. Time to right the wrongs: improving basic health care in Nigeria. (0140-6736 (Print)).
Famuyiwa Oo Fau - Edozien, E. M., Edozien Em Fau - Ukoli, C. O., & Ukoli, C. O. Social, cultural and economic factors in the management of diabetes mellitus in Nigeria. (0309-3913 (Print)).
Neumann, P. J., Stone, P. W., Chapman, R. H., Sandberg, E. A., & Bell, C. M. (2000). The quality of reporting in published cost-utility analyses, 1976-1997. Ann Intern Med, 132(12), 964-972. doi:10.7326/0003-4819-132-12-200006200-00007
Past, present, and future of global health financing: a review of development assistance, government, out-of-pocket, and other private spending on health for 195 countries, 1995-2050. (2019). Lancet, 393(10187), 2233-2260. doi:10.1016/s0140-6736(19)30841-4
| Files | ||
| Issue | Vol 11 No 03 (2025) | |
| Section | Review Article(s) | |
| Keywords | ||
| Assessment Nigeria Systematic Review Cost Evaluation | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
